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ABSTRACT 
Objectives: The Techniques for Overcoming Depression (TOD) questionnaire assesses the 
frequency with which patients being treated for depression use cognitive-behavioral techniques 
in daily life. This study examined its latent structure, reliability and concurrent validity in 
depressed cardiac patients. 
Method: The TOD was administered at the initial and final treatment sessions in three trials of 
cognitive behavior therapy (CBT) (n = 260) for depression in cardiac patients. Mokken scaling 
was used to determine its dimensionality. 
Results: The TOD is unidimensional in depressed cardiac patients, both at the initial evaluation 
(H = .46) and the end of treatment (H = .47). It is sensitive to change and the total score 
correlates with therapist ratings of the patient’s socialization to CBT (r=.40, p<.05), homework 
adherence (r=0.36, p<0.05), and use of cognitive-behavioral techniques (r=.51, p<.01). TOD 
scores were associated with post-treatment depression scores in two of the trials (p<.01 in both 
analyses). 
Conclusions: The TOD is a unidimensional, reliable, valid, and clinically informative measure 
of self-reported use of cognitive-behavioral techniques for overcoming depression in cardiac 
patients. Studies of the TOD in other depressed patient populations are needed. 
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Several variants of cognitive behavior therapy (CBT) have been evaluated in randomized 
controlled trials (RCTs) as treatments for depression in adults. The classic manual by Beck et al. 
(Beck, Rush, Shaw, & Emery, 1979) focuses primarily on cognitive restructuring but also 
includes other intervention components. There is ample evidence that Beck’s and other 
multicomponent varieties of CBT are efficacious relative to several different comparators. 
However, other trials and meta-analyses have shown that certain components of CBT, especially 
behavioral activation and problem-solving, if delivered as stand-alone interventions, are 
approximately as efficacious for depression as is multicomponent CBT (Barth et al., 2013; Bell 
& D'Zurilla, 2009; Cuijpers, van, & Warmerdam, 2007; Cuijpers et al., 2013; Dimidjian et al., 
2006; Jacobson et al., 1996; Nezu & Perri, 1989).  
 For example, a randomized dismantling trial recently compared mindfulness-based cognitive 
therapy to standard cognitive therapy and to treatment as usual in 274 patients with recurrent 
depression who were recruited from primary care and mental health facilities. The outcomes of 
both forms of cognitive therapy were similar, and relapse rates were similar with or without the 
mindfulness component (Williams et al., 2014). These and the earlier findings cited above raise 
questions about the incremental clinical value of including more than one or two components in 
cognitive-behavioral interventions for depression. However, an analysis of treatment process 
data from the intervention arm of the Enhancing Recovery in Coronary Heart Disease 
(ENRICHD) clinical trial showed that patients who were exposed to most or all of the 
ingredients of the trial’s multicomponent cognitive-behavioral intervention (which was guided 
by Beck’s manual) tended to have better depression outcomes than patients who were exposed to 
fewer components (Cowan et al., 2008).  
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 In trials of individualized cognitive-behavioral interventions for depression, different patients 
may be exposed to different treatment components or combinations of components. Patients may 
also differ as to which cognitive-behavioral techniques they adopt and rely on to overcome 
depression, but few studies have examined this question. The Ways of Responding (WOR) scale 
(Barber & DeRubeis, 1992) was developed to assess patient competence with the kinds of coping 
skills that are typically encouraged by cognitive therapists. The WOR is sensitive to treatment-
related change (Barber & DeRubeis, 2001), covaries with change in depression (Barber & 
DeRubeis, 2001), and predicts relapse of depression after treatment (Barber & DeRubeis, 1992; 
Strunk, DeRubeis, Chiu, & Alvarez, 2007).  However, the WOR is a relatively complex thought-
listing instrument that asks patients to imagine how they will respond to depressive thoughts in a 
variety of stressful situations and to answer a series of additional questions about each situation. 
Given the complexity of the WOR and its restricted focus on cognitions, there is a need for a 
questionnaire that is simpler for patients and therapists to use and that assesses a broader range of 
the cognitive-behavioral techniques that depressed patients may use in daily life. Consequently, 
we developed the Techniques for Overcoming Depression (TOD) questionnaire as a clinical 
assessment tool for use in multicomponent CBT interventions. The TOD assesses the number 
and type of cognitive-behavioral techniques that patients report using to overcome their 
depression, and the frequency with which they have been using these techniques in daily life. 
The purpose of this study was to evaluate the psychometric structure, reliability, and 
concurrent validity of the TOD, and to test the hypothesis that depressed cardiac patients who 
report using multiple cognitive-behavioral techniques, and using them frequently, tend to have 
better depression outcomes than similar patients who report using fewer techniques and/or using 
them infrequently. Because CBT homework assignments often involve using these techniques 
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between sessions, and because a patient’s willingness to use them is presumably influenced by 
his or her socialization to CBT, we also investigated the relationships between the TOD and 
therapist ratings of socialization to CBT and homework adherence. Specifically, we 
hypothesized that 1) the individual TOD item ratings and the TOD total score increase from the 
initial clinical evaluation to the end of active treatment; 2) there are positive correlations between 
the TOD scores and therapist ratings of the patient’s use of cognitive-behavioral techniques in 
daily life, homework adherence, and socialization to CBT; and 3) TOD scores predict depression 
scores at the end of treatment. Because much of our research focuses on the role and treatment of 
depression in heart disease, we tested these hypotheses on data from randomized controlled trials 
of CBT for depressed cardiac patients. The TOD is intended for use in a wide variety of 
depressed populations, not only in depressed cardiac patients, but it should not be used for 
clinical purposes in other populations until it has been tested in those populations. 
 
Method 
Development of the TOD Questionnaire 
The TOD is a 16-item, self-report questionnaire. Each item presents one of the techniques or 
strategies that are often promoted in multicomponent cognitive-behavioral interventions for 
depression, e.g., “Challenge the depressing thoughts and images that run through my mind, and 
practice more helpful ways of thinking.”  Each item is rated on a 4-point scale (0, never or rarely; 
1, sometimes; 2, often; 3, very often).  The TOD total score is the sum of the 16 item ratings and 
ranges from 0 to 48. A score of zero would indicate that the patient is not using any of the listed 
techniques, whereas a score of 48 would suggest that the patient is frequently using all of the 
techniques. The instrument is displayed in Appendix A. 
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 To develop the questionnaire, we first reviewed the depression treatment manual by A.T. 
Beck (Beck et al., 1979), two cognitive therapy manuals by J.S. Beck (Beck, 1995; Beck, 2005), 
and materials from several CBT training workshops to identify techniques that are often used to 
treat depression. We reviewed the CBT case files and audio recordings from the St. Louis site of 
the ENRICHD trial (Berkman et al., 2003) and from three other cognitive-behavioral depression 
trials that had been conducted in cardiac patient populations at this site (Freedland et al., 2002; 
Carney et al., 2000; Lustman, Freedland, Griffith, & Clouse, 1998) to identify frequently-used 
techniques. The 16 most frequently used techniques were then described in layperson’s terms, 
based on the in-session descriptions of these techniques by multiple patients who had been using 
them in their daily lives during trials involving cognitive-behavioral interventions at our center. 
These items were then reviewed and edited by several of the cognitive behavior therapists, CBT 
supervisors, principal investigators, and co-investigators who were involved in these trials. The 
final wording of the items was based on the consensus judgment of this group. The scale was 
finalized before being used in three additional trials at our center. The data used in the present 
analyses were derived from these trials. 
 
Participants 
The data for the present analyses were obtained from the CBT arm of a completed RCT 
involving patients with depression and a recent history of coronary artery bypass graft (CABG) 
surgery (n = 35) (Freedland et al., 2009), the intervention arm of a recently completed RCT of 
CBT for depression in patients with heart failure (n = 79) (Freedland, Carney, Rich, Steinmeyer, 
& Rubin, 2015), and an uncontrolled trial of CBT and antidepressant medication to identify 
treatment-resistant depression in patients with coronary heart disease (n = 157) (Carney et al., 
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2016), for a total sample size of n = 271.  The therapists in these trials had masters degrees in 
social work or counseling or doctoral degrees in clinical psychology, had advanced training and 
experience in CBT, and were supervised by the first author.  
The patients and protocols differed across these studies. The Depression Interview and 
Structured Hamilton (DISH) (Davidson et al., 2006; Freedland et al., 2002) was used in all three 
trials to determine the depression diagnosis at baseline.Thirty-seven percent of the participants in 
the CBT arm of the CABG trial met the DSM-IV criteria for minor depression, 63% met the 
criteria for major depression at baseline, 68% had a prior history of major depression, and they 
scored an average of 22.3 on the BDI at baseline. Fifty-four percent of them were on a nonstudy 
antidepressant medication during the trial, and they were given 12 weeks of individual CBT. The 
participants in the heart failure trial had major depression and scored an average of 30.7 on the 
baseline BDI. They were offered up to 6 months of individual CBT, but weekly sessions ended 
and the maintenance phase began when the patient met criteria for remission of depression. 
Consequently, the participants completed an average of 10.8 + 5.8 sessions. Thirty-three percent 
of the participants were taking a nonstudy antidepressant. The participants in the treatment-
resistant depression study had major depression with average baseline BDI scores of 30.2, and 
they were treated with up to 16 sessions of CBT, either alone or in combination with an 
antidepressant. Forty-nine percent of the patients were already taking an antidepressant at 
baseline, and 15% were placed on an antidepressant during the trial.  
Complete TOD item data were available at the initial clinical evaluation in n = 260 (96%) of 
these cases, and data from the end of active treatment were available in n = 212 (78%) of the 
cases. Depression outcome data were available from n = 34 patients in the CBT arm of the 
CABG study and n = 56 patients in the CBT arm of the heart failure study. 
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The mean age in the combined sample was 59.1 years (SD, 10.0); 75% (n = 203) were 
Caucasian and 45% (n = 121) were female. All three studies were approved by the institutional 
review board (IRB) at Washington University Medical Center in St. Louis, Missouri. All 
participants provided written informed consent on IRB-approved consent forms. 
 
Measures 
The Beck Depression Inventory (BDI) (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961) was 
administered to assess the severity of depression in the the post-CABG and treatment-resistant 
depression trials. The Patient Health Questionnaire (PHQ-9) (Kroenke, Spitzer, & Williams, 
2001) was used to assess the severity of depression in the heart failure trial. 
 Also in the heart failure trial, the therapists rated three aspects of patient engagement in 
therapy, based on rating scales that were created as clinical tools for this trial. The ratings 
included 1) socialization to CBT, 2) adherence to CBT homework assignments, and 3) use of 
cognitive-behavioral techniques in daily life. Each item was rated on a 7-point scale ranging 
from 0 to 6. The socialization rating ranged from 0 (patient has little or no understanding of the 
CBT model or of his/her role in treatment) to 6 (patient has excellent understanding of all 
relevant aspects of the CBT model and his/her role in treatment). The homework rating ranged 
from 0 (patient is unwilling to do any homework or did not comply at all with the latest 
assignment) to 6 (patient sees homework as an important and valuable part of his/her treatment 
and was fully compliant with latest assignment). The use of cognitive-behavioral techniques item 
ranged from 0 (patient has little or no skill in cognitive-behavioral techniques [e.g., challenging 
distorted thinking] or isn’t using them) to 6 (patient has excellent cognitive-behavioral skills and 
uses them effectively in daily life). The therapists recording these ratings after each therapy 
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session, based on their clinical observations during the session. The final ratings (i.e., the ones 
that were used in the present analysis) were completed before the patient completed the TOD. 
Thus, the patient’s responses on the TOD did not influence the therapist’s ratings.  
 
Procedure 
The TOD was administered to participants in the CBT arm, twice during each trial: at the initial 
clinical evaluation and at the termination of active cognitive-behavioral treatment. In the post-
CABG and treatment-resistant depression trials, the participants completed the BDI at the 
baseline evaluation and again at the 12-week, post-treatment evaluation. Similarly, in the heart 
failure trial, patients completed the PHQ-9 at the baseline evaluation and at the 6-month post-
treatment evaluation.  
 
Statistical Analyses 
A mixture of classical and modern psychometric methods were used to assess the TOD. 
Exploratory factor analysis and Mokken scaling were used to determine the dimensionality of the 
TOD. A scree plot and the parallel process method following a principal components analysis 
informed the decision of how many factors to retain (Hayton, Allen, & Scarpello, 2004). Stata 
13.0 was used to conduct the Mokken scale analysis with a procedure written by Jean-Benoit 
Hardouin (Hardouin, 2004).  
Mokken scaling was chosen because it is nonparametric; parametric item response theory 
(IRT) techniques require larger sample sizes than were available. Mokken scaling determines the 
dimensionality and hierarchy of scale items, and has previously been used with measures of 
depressive symptoms in cardiac patients (Cosco, Doyle, Watson, Ward, & McGee, 2012; Doyle, 
Conroy, McGee, & Delaney, 2010). It is based on Guttman scaling, in which a positive 
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endorsement of a binary item of given difficulty indicates that remaining items of lesser 
difficulty have also been endorsed (Guttman, 1950). Mokken scaling is a probabilistic version of 
this procedure which can also evaluate polytomous items (Meijer & Baneke, 2004; Stochl, Jones, 
& Croudace, 2012). The item means are used to represent the level of item difficulty. 
Loevinger’s H coefficient (Loevinger, 1948) is an estimate of the expected errors (probability 
that the items are chosen by chance) and observed errors (number of times items are endorsed as 
if not in an ordered sequence). The formula is: Hi = [1 – (observed Guttman errors/predicted 
Guttman errors)]. Higher Hi values indicate better item discrimination along the latent trait, and 
the mean Loevinger H for all items is the overall scale H. Mokken scales are interpreted as 
follows: .30≥H<.40 ‘weak’, .40≥H<.50 ‘moderate’ and H≥.50 ‘strong’ (Meijer & Baneke, 2004). 
A recommended analysis procedure was followed, which involves increasing the lower bound 
threshold for the item-scalability coefficients (c), commencing with c=.01, then c=.05 and 
increasing in steps of .05 until c=.60 (Meijer & Baneke, 2004). Nondiscriminating items are 
excluded, depending on the threshold chosen, and the most interpretable solution is adopted. This 
report includes findings from Mokken analyses with the lower bound coefficient set at .35. We 
predicted that the TOD would form a unidimensional scale both at baseline and at follow-up, and 
that this would be found by both factor analytic and Mokken techniques. In response to recent 
recommendations and controversies (Dunn, Baguley, & Brunsden, 2014), internal consistency 
reliability was assessed with Cronbach’s alpha and MacDonald’s omega, using bootstrapping 
with 1000 replications to determine the bias-corrected 95% confidence intervals (CIs). 
Using data from the post-CABG depression trial, correlations between the TOD total scores 
and the therapist’s independent ratings of the patient’s engagement in CBT at the end of active 
treatment were computed in order to evaluate the concurrent validity of the TOD. A high positive 
11 
 
correlation between the TOD total score and the therapist’s rating of “patient’s use of cognitive-
behavioral techniques” would be consistent with a high level of agreement about the extent to 
which the patient is using these techniques in everyday life. Positive correlations between the 
TOD and the other therapist rating scales would indicate that patients who report frequently 
using multiple techniques tend to exhibit a better understanding and acceptance of the cognitive-
behavioral model, and greater adherence to CBT homework assignments, compared to patients 
who report using relatively few techniques in daily life. 
Paired t-tests were used to compare TOD total scores between the initial clinical evaluation 
and the end of treatment. We hypothesized that the mean score would be significantly higher at 
the end of treatment than at the initial evaluation, consistent with the therapeutic objectives of 
helping patients to acquire cognitive-behavioral coping skills and of encouraging them to apply 
these skills in daily life to overcome their depression.  Mean differences were also tested for the 
individual items. We hypothesized that on average, every item rating would increase between the 
initial clinical evaluation and the end of treatment. 
 Proc Mixed in SAS 9.3 (SAS Institute, Cary, NC) was used to conduct mixed model analyses 
of the association between TOD scores and BDI scores in the CABG trial, and between TOD 
scores and PHQ-9 scores in the heart failure trial. The depression outcome data from the 
treatment-resistant depression study were not yet available when the combined dataset for the 
present analysis was created. The data were fitted to linear mixed models with autoregressive 
(AR-1) covariance structures. In each model, the outcome variable was the depression score at 
the end of active treatment, and the fixed effects included the TOD scores at the initial evaluation 
and at the end of active treatment, and the depression score at the initial evaluation. We 
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hypothesized that high TOD scores would be associated with lower depression scores at the end 
of active treatment. 
 
Results 
Both the scree plot and the parallel process methods after exploratory factor analysis indicated 
that a single dimension was the best fit both at baseline and at follow-up (see Appendix A). The 
first factor explained 43% and 46% of the variance at baseline and follow-up, respectively. The 
results of the Mokken analyses confirmed this unidimensional solution, and are shown in Table 
1. At the initial clinical evaluation, analysis of all items at scalability threshold c=.35 yielded a 
single, 15-item “moderate” Mokken scale (H=.46), which omitted item #1 but retained all other 
items in this unidimensional solution. Analysis at higher scalability thresholds simply omitted 
further items, or did not lead to interpretable scales. A similar analysis of the TOD data from the 
end of active treatment again demonstrated a moderate unidimensional scale (H=0.47), but this 
time retained all 16 items. Cronbach’s alpha at baseline was .92 (95% CI .89 to .93), while 
MacDonald’s omega was .91 (95% CI .89 to .93). At follow-up alpha was .92 (95% CI .90 to 
.94), with an omega of .92 (95% CI 0.90 to 0.94), indicating excellent reliability. 
Paired t-tests were used to compare TOD scores between the initial evaluation and the end of 
treatment in the overall sample as shown in Table 1. The TOD total score and all of the item 
ratings were significantly higher at the end of treatment than at the initial clinical evaluation (all 
p values < .001), consistent with the therapeutic objectives of CBT.  The effect size for pre-post 
change on the total score was d = 2.06 (95% C.I., 1.85 – 2.32). 
Using data from the end-of-treatment evaluation in the post-CABG depression trial, positive 
correlations were found between the TOD score and the therapist ratings of patient´s 
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socialization to CBT (i.e., the patient’s level of understanding of the cognitive model and of his 
or her role in treatment), adherence to cognitive-behavioral homework assignments, and use of 
cognitive-behavioral techniques in daily life. The BDI score at the end of active treatment 
correlated inversely with TOD total score. The correlations are displayed in Table 2. The 
therapist ratings themselves were positively intercorrelated. Use of cognitive-behavioral 
techniques correlated r = 0.92 (p<.0001) with socialization to CBT and r = 0.56 (p=.0003) with 
patient adherence to homework, and socialization to CBT correlated r = 0.55 (p=.0003) with 
adherence to homework.   
A linear mixed model, fitted to the CABG trial data, showed a significant, inverse 
relationship over time between the TOD and the BDI (intraclass correlation [ICC] = -.43; b 
(95%CI) = -.17 (-.07, -.27); t = -3.52; df = 48; p=.001). A similar model of data from the heart 
failure trial supported the hypothesis of an inverse relationship over time between the TOD and 
the PHQ-9 (ICC = -.26; b (95% CI) = -.08 (-.03, -.14); t = -3.05; df = 103; p=.003).  Both the 
BDI and the PHQ-9 demonstrated high reliability in these trials (BDI: alpha = 0.84 at the initial 
evaluation and 0.93 at the end of treatment; PHQ-9: alpha = 0.80 at the initial evaluation and 
0.82 at the end of treatment). 
 
Discussion 
The Techniques for Overcoming Depression questionnaire assesses the number of cognitive-
behavioral techniques that patients adopt and the frequency with they use them in daily life to 
overcome depression. It captures an important aspect of the patient’s perspective on CBT for 
depression, and it does so in terms that are understandable to patients, consistent with recent 
recommendations regarding outcome measures in psychiatric research (Arfken & Balon, 2014).  
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The results of this study show that the TOD is a unidimensional measure when administered 
to depressed cardiac patients, and that it has excellent reliability, both when administered at the 
initiation of CBT and when readministered at the end of active treatment. Every item except for 
item #1 (finding more or better emotional support from other people) exceeded the Hi > .35 
threshold for retention at the initial clinical evaluation, and every item including #1 exceeded this 
threshold at the end of active treatment. We retained this item because of its clinical utility, 
relatively high frequency of endorsement, and satisfactory H value at the end of active treatment. 
In addition, it scaled with all of the other items at a lower threshold (c = .20, data not shown). 
The fact that this item scaled better at the end than the initiation of treatment perhaps suggests 
that it assesses a technique that people with depression initially underutilize but that they tend to 
adopt as they progress through therapy. Future work should investigate the utility of this item. 
One of the defining characteristics of a Mokken scale is that patients who endorse relatively 
difficult items (i.e., items with low mean ratings) also tend to endorse the less difficult items. For 
example, patients who reported on the initial assessment that they had been practicing stress 
management and relaxation techniques (item #14; mean, .75) also tended to report that they had 
been reviewing their priorities, values, or goals in life (item #7; mean, 1.06).  
Ideally, the difficulty level of each item should differ from those of the adjacent items, but 
this is not the case for some of the TOD items.  For example, the difficulty levels are identical at 
the end of active treatment for item #6 (coping with hard realities) and #7 (reviewing priorities, 
values, or goals).  If the TOD were too lengthy, it would be possible to drop one of these items 
without losing any ability to locate patients along the underlying latent dimension of the 
“tendency to use CBT-based techniques to overcome depression”.  However, the TOD is not a 
very lengthy instrument for use in the context of a CBT session, and the individual items may be 
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as clinically informative as the total score. In addition, different patients may utilize different but 
equally difficult techniques. Thus, although some of the item difficulty levels are closer together 
than might be preferable, this is not a very compelling reason to eliminate any of the items from 
the questionnaire. With 16 items, the TOD achieves an acceptable balance between depth of 
measurement and respondent burden (Ryff, 2014). 
Comparison of the items and the total scores at the initial evaluation vs. the end of active 
treatment show that the TOD is sensitive to treatment-related change. On average, the total score 
approximately doubled between the initial clinical evaluation and the end of active treatment 
across three different trials of CBT for depression in cardiac patients. This indicates that after 
exposure to CBT, patients tend to report that they are using a wider variety of cognitive-
behavioral techniques to overcome their depression, and using these techniques more frequently 
than prior to treatment. This is consistent with the clinical objectives of multicomponent CBT 
(Hundt, Mignogna, Underhill, & Cully, 2013). 
The mean of every TOD item also increased between the intial evaluation and the end of 
active treatment. In addition, there were some changes in the rank order of the item difficulties 
between the two assessments. For example, item #4 (challenging negative ideas about self) 
moved from being the 5th most difficult item on the initial assessment to the 12th at the end of 
active treatment. This suggests that CBT does more than simply reinforce the same techniques 
that patients were already using before therapy; it also encourages them to try new ones.  
 We examined the relationships between TOD scores and several therapist ratings at the end 
of active treatment in a post-CABG depression trial to evaluate the concurrent validity of the 
TOD. The strongest correlation was between the TOD total score and the therapist’s independent 
rating of the patient’s use of cognitive-behavioral techniques to overcome depression and related 
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problems in daily life. The TOD score also correlated with the therapist’s rating of the patient’s 
socialization to CBT and of his or her adherence to CBT homework assignments. Thus, the TOD 
tends to corroborate what therapists learn through various means (e.g., by including a “past week 
review” on the session agenda and by reviewing homework assignments) about the patient’s 
acquisition and application of cognitive-behavioral skills. The TOD accounts for 16% to 26% of 
the variance in the therapist ratings. These are significant effects yet they imply that there is quite 
a bit of unexplained variance and they suggest that the TOD provides additional information 
about the patient’s use of cognitive-behavioral techniques, above and beyond other methods that 
therapists may use to assess their patients’ progress in therapy. 
The therapist ratings correlated even more strongly with some of the individual TOD items 
than they did with the TOD total score. For example, the therapist’s rating of the patient’s 
socialization to CBT correlated .52 with the use of relaxation and stress management techniques 
and .62 with self-management of health problems or health care, compared to only .40 with the 
TOD total score. This suggests that patients who fully embrace the cognitive model and become 
actively engaged in treatment tend to rely more heavily on some techniques than others. Some 
patients may limit themselves to one or two techniques because of the relative emphasis that 
their therapist places on those particular techniques. However, the moderately strong correlations 
of the TOD total score with the therapist ratings also suggest that it tends to be better for patients 
to try a variety of techniques for overcoming depression than to rely on only one or two 
techniques. This is consistent with one of the core strategies of CBT, i.e., encouraging patients to 
experiment with new ways to cope with their problems and overcome their emotional distress 
(Hundt et al., 2013).  
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The TOD total score and most of the TOD items correlated significantly with end-of-
treatment BDI scores in the post-CABG depression trial. In addition, TOD change scores 
predicted post-treatment BDI scores in the CABG trial and post-treatment PHQ-9 scores in the 
heart failure trial even after controlling for the self-reported severity of depression at baseline. It 
is not possible to determine from these findings whether increased use of cognitive-behavioral 
techniques plays a causal role in depression improvement. Nevertheless, increases in TOD total 
scores predict better depression outcomes in CBT. This suggests that the TOD has utility as an 
indicator of clinical progress. It also provides evidence that in multicomponent CBT for 
depression, better outcomes are associated with frequent utilization of multiple cognitive-
behavioral techniques. This is consistent with a secondary analysis of data from the ENRICHD 
clinical trial which revealed a significant inverse relationship between the number of components 
of CBT to which patients were exposed and post-treatment depression scores (Cowan et al., 
2008). More research is needed to clarify the implications of this association, given evidence that 
favorable outcomes can also be achieved with fewer treatment components, such as in behavioral 
activation (Cuijpers et al., 2007) and problem-solving interventions (Bell & D'Zurilla, 2009). 
Two items that showed relatively low correlations with the BDI at the end of treatment 
concern cognitive restructuring: challenging depressing thoughts and images, and challenging 
depressing beliefs and attitudes. This is surprising, given the centrality of cognitive restructuring 
in multicomponent CBT for depression. However, when working with depressed, medically ill 
patients, therapists often rely more heavily (at least initially) on behavioral than on cognitive 
strategies. Behavioral components such as behavioral activation, and practical efforts to address 
health-related problems, may play more prominent roles than cognitive techniques in the 
treatment of many medically ill patients (Skala, Freedland, & Carney, 2005). 
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It is often necessary to adapt cognitive-behavioral interventions to accommodate the 
functional limitations that are imposed by chronic medical illness. For example, in all three of 
the trials that supplied the data for this report, some of the sessions were conducted by telephone 
in order to overcome transportation- or infirmity-related barriers. In most other respects, 
however, these interventions are no different than the ones used to treat depressed but otherwise 
medically well patients. TOD item #16 (“Learn more about how to manage my health problems 
or how to get good health care”) may be less somewhat less relevant when CBT is used to treat 
depression in otherwise medically well patients, although given the high prevalence of somatic 
complaints in these patients (Simon, VonKorff, Piccinelli, Fullerton, & Ormel, 1999), this item 
could have broader relevance than it may seem. Studies of the TOD in depressed but otherwise 
medically well patients are needed to investigate this question. 
The symptoms of major depression do not differ in any well-established, systematic way 
between medically ill and medically well patients (Freedland, Lustman, Carney, & Hong, 1992; 
Lustman, Freedland, Carney, Hong, & Clouse, 1992).  In addition, there are more similarities 
than differences in the treatment of depression between medically ill and medically ill patients, 
and most of the differences are due to safety or accessibility issues (Freedland & Carney, 2014). 
Little is known about whether there are any important differences between medically ill and 
medically well patients, or between patients with different medical conditions, in the techniques 
for overcoming depression that they adopt when treated with CBT.  The TOD scale is likely to 
be a useful measure in research in this area.             
The TOD assesses the self-reported frequency of use of cognitive-behavioral techniques for 
overcoming depression, but it does not assess the quality of CBT skill use. As discussed in a 
recent review (Hundt et al., 2013), there is evidence that favorable depression outcomes depend 
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both on the frequency of CBT skill use and on proficiency with these skills. Thus, if a patient’s 
depression scores are not improving despite relatively high scores on the TOD, the therapist 
should evaluate whether the highest-frequency techniques are being used in an effective manner, 
and focus on further skill development if any deficits are identified. 
Many other psychotherapy process variables have been examined in previous studies, and the 
TOD may be as strong of a predictor of treatment outcomes as some of the most frequently 
investigated processes variables, or perhaps even stronger. For example, a recent meta-analysis 
of psychotherapy studies (Horvath, Del Re, Fluckiger, & Symonds, 2011) found an overall 
correlation between therapeutic alliance measures and treatment outcomes of .28 (95% C.I., .25 - 
.30). In contrast, end-of-treatment TOD scores correlated -.26 with post-treatment PHQ-9 scores 
in our heart failure trial and -.43 with post-treatment BDI scores in our CABG trial. As another 
example, a meta-analysis of therapist adherence and competence studies (Webb, DeRubeis, & 
Barber, 2010) found that neither factor was a significant predictor of therapy outcomes. Whether 
the TOD is an independent predictor of depression outcomes in CBT after controlling for other 
process measures is unknown and should be studied. However, the patient’s use of cognitive-
behavioral techniques in daily life is a clinically important indicator of therapeutic progress in 
CBT, regardless of whether the TOD has independent predictive value.  
Limitations 
This study has several limitations. First, the data were combined from three different trials. CBT 
was used to treat depression in every trial, but the study protocols differed in ways that might 
have affected the present results. For example, the post-treatment assessments occurred at 
different intervals. Second, all of the participants were cardiac patients with depression as a 
comorbid condition. Consequently, the generalizability of the present findings to other medically 
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ill patients, or to depressed but otherwise medically well patients, remains to be evaluated. None 
of the TOD items allude specifically to heart disease, so the questionnaire will not have to be 
modified for studies of other patient populations.  Third, some of the participants in these trials 
were taking antidepressants in addition to participating in CBT, but data on antidepressants were 
not available in our composite analysis dataset.  It is possible that antidepressant use could have 
influenced some of the pre-post increases in TOD scores as well as the strength of their 
relationship to depression outcomes. Fourth, the validity correlations were based on a relatively 
small sample of participants in a single trial, and no data pertaining to the instrument’s 
discriminant validity were available. Further research on the clinical validity and utility of the 
TOD questionnaire is needed. Studies with larger sample sizes would permit the use of more 
sophisticated item response theory methods to more stingently evaluate the scale and its 
individual items. Fifth, no objective behavioral data were collected on the patients’ actual use of 
cognitive-behavioral techniques in daily life. Consequently, it was not possible to evaluate 
accuracy of the patients’ self-reported data. This is an important aspect of the construct validity 
of the TOD that warrants further investigation. Finally, this study was not designed to determine 
whether the patient’s use of cognitive-behavioral techniques in daily life plays a causal role in 
the remission of depression. Additional research is needed to determine whether increases in 
TOD scores mediate treatment-related decreases in depression scores. 
 
Conclusion 
The results of the study suggest that the TOD is a valid clinical tool for use in CBT for 
depression in cardiac patients. A review of progress since the initiation of treatment is an 
important agenda item for the end of active treatment. Change on the TOD is a clinically useful 
indicator of the extent to which the patient is applying cognitive-behavioral skills in daily life. In 
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the three trials included in the present analysis, the therapists have presented their depressed 
cardiac patients with a side-by-side comparison of the initial and final TOD questionnaires at the 
end of active treatment. Most patients are surprised to see how few techniques they were using 
prior to treatment, and how many techniques they have been using lately. This helps them to 
understand that they have been playing an active role in their own recovery, and that they will be 
able to use these same techniques to help prevent relapses and, if necessary, to overcome future 
episodes of depression. In addition, the TOD serves as a reminder of techniques that the patient 
has not been using frequently but that could be helpful when needed. Consequently, the pre-post 
TOD comparison is often one of the most clinically useful activities on the end-of-treatment 
agenda.  
In summary, the Techniques for Overcoming Depression (TOD) questionnaire is a reliable, 
unidimensional scale that is sensitive to treatment-related change and clinically useful in 
multicomponent CBT for depression in patients with heart disease. Further research is needed to 
evaluate its validity and utility, especially in other patient populations, and to determine whether 
additional refinements might improve the instrument. Future work should investigate the utility 
of Item #1, specifically whether it is worth retaining in its current form, whether it requires re-
wording, or whether it is truly only applicable toward the end of therapy. Research on the 
relationship between TOD ratings and ecological momentary assessments of the use of 
cognitive-behavioral techniques would also be informative. 
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Table 1.  Mokken scale analysis of the TOD Questionnaire and its sensitivity to change* 
 
Item 
Initial Clinical Evaluation 
(n = 260) 
End of Active Treatment 
(n = 212) 
Mean (S.D.) Hi Mean (S.D.) Hi 
  1. Increase emotional support   1.02 (0.81)   1.70 (0.79) .38 
  2. Challenge depressing thoughts and images   1.05 (0.81) .43  2.24 (0.74) .44 
  3. Challenge depressing beliefs and attitudes   0.99 (0.84) .46  2.27 (0.73) .54 
  4. Challenge negative ideas about self   0.91 (0.86) .48  2.14 (0.78) .50 
  5. Identify counterproductive coping strategies   0.95 (0.79) .39  1.88 (0.84) .47 
  6. Cope with hard realities of life   1.04 (0.86) .47  2.12 (0.76) .49 
  7. Review priorities, values, or goals   1.06 (0.83) .47  2.12 (0.77) .45 
  8. Cope with everyday hassles and problems   1.05 (0.76) .50  2.30 (0.72) .50 
  9. Improve social life   0.74 (0.78) .44  1.94 (0.82) .45 
10. Increase pleasant activities   0.92 (0.73) .44  2.04 (0.86) .48 
11. Increase productive activities   0.99 (0.75) .48  2.05 (0.78) .46 
12. Active problem-solving   0.93 (0.70) .50  2.13 (0.71) .53 
13. Overcome adversity   1.22 (0.74) .48  2.07 (0.77) .50 
14. Relaxation and stress management   0.75 (0.80) .43  2.10 (0.86) .48 
15. Improve skills for difficult social situations   0.89 (0.75) .50  1.98 (0.79) .47 
16. Manage health problems or health care   1.62 (0.82) .38  2.25 (0.79) .41 
 TOD total score 16.33 (8.24) H=.46 33.68 (8.67) H=.47 
 
*All paired t-tests comparing initial and end-of-treatment scores were significiant at p < 0.001.  
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Table 2. Pearson correlations between TOD items, therapist ratings, and BDI score at end of active treatment (n=34). 
 
Item 
Therapist Ratings 
BDI Total 
Score 
Socialization 
To CBT 
Homework 
Adherence 
Use of CBT 
Techniques 
1. Increase emotional support .37* .43* .43* -.42* 
2. Challenge depressing thoughts and images .13 .00 .23 -.21 
3. Challenge depressing beliefs and attitudes .23 .10 .34 -.33 
4. Challenge negative ideas about self .26 .27 .40* -.44* 
5. Identify counterproductive coping strategies .26 .34 .32 -.40* 
6. Cope with hard realities of life .14 .07 .29 -.33 
7. Review priorities, values, or goals .21 .24 .22 -.42* 
8. Cope with everyday hassles and problems .33 .22 .40* -.52** 
9. Improve social life .19 .40* .28 -.42* 
10. Increase pleasant activities .45** .38* .51** -.53** 
11. Increase productive activities .33 .26 .39* -.43* 
12. Active problem-solving .29 .22 .49** -.40* 
13. Overcome adversity .19 .19 .39* -.48** 
14. Relaxation and stress management .52** .48** .59*** -.48** 
15. Improve skills for difficult social situations .43* .41* .54** -.50** 
16. Manage health problems or health care .62*** .49** .60*** -.53** 
TOD total score .40* .36* .51** -.55*** 
 
*p<.05  **p<.01  ***p<.001
 Appendix A 
Techniques for Overcoming Depression (TOD) Questionnaire 
Instructions: These are some of the techniques that can help people to overcome their depression.  
Some of them may be more helpful or important for you than other ones are.  Lately, how often 
have you been using these techniques? 
 
  
Never 
or 
Rarely 
0 
Sometimes 
1 
Often 
2 
Very 
Often 
3 
1. Find more or better emotional support from 
other people. 
0 1 2 3 
2. Challenge the depressing thoughts and 
images that run through my mind, and 
practice more helpful ways of thinking. 
0 1 2 3 
3. Challenge my depressing beliefs and 
attitudes, and work on replacing them with 
more helpful beliefs and attitudes. 
0 1 2 3 
4. Challenge the negative ideas I have about 
myself, and work on replacing them with 
ideas that will improve my self-esteem. 
0 1 2 3 
5. Figure out if I’m doing something to help or 
protect myself that actually makes my 
problems worse or makes me feel worse, and 
work on finding better ways to take care of 
myself 
0 1 2 3 
6. Develop better ways to cope with the hard 
realities of life (especially problems that are 
beyond my control, like having a serious 
illness or losing a loved one). 
0 1 2 3 
7. Review my priorities, values, or goals in life, 
and work to change whatever is getting in the 
way of having a better life. 
0 1 2 3 
8. Improve my ability to cope with everyday 
hassles and problems. 
0 1 2 3 
9. Work on improving my social life, spending 
more time with other people I enjoy, or 
meeting new people. 
0 1 2 3 
10. Get more active doing things I enjoy or get 
pleasure out of, such as recreational activities, 
hobbies, reading, travel, etc. 
0 1 2 3 
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Never 
or 
Rarely 
0 
Sometimes 
1 
Often 
2 
Very 
Often 
3 
11. Get more active doing things that give me a 
sense of accomplishment or achievement, or 
that make me feel that I’m doing something 
useful, important, or helpful. 
0 1 2 3 
12. Actively work on solving the problems that 
get me down. 
0 1 2 3 
13. If something important is not going the way I 
want it to, figure out what I can do to make it 
go better. 
0 1 2 3 
14. Practice techniques for relaxing and 
managing stress. 
0 1 2 3 
15. Improve my skills for dealing with difficult 
social situations, such as learning how to be 
more assertive, finding better ways to 
communicate, controlling my anger, etc. 
0 1 2 3 
16. Learn more about how to manage my health 
problems or how to get good health care. 
0 1 2 3 
17. Other (describe): 
 
 
Total score: _________
 Appendix B 
 
B1: Scree plots at baseline and follow-up, with parallel analysis indicating random eigenvalues. 
Parallel analysis compares a random dataset with the same number of observations and variables 
to the current data. We used 1000 replications, so the results indicate the average eigenvalues of 
these replications. 
 
 
We retained only one factor, as the acute inflection after the first factor in the plot indicates that a 
single factor solution is best. In the parallel analysis, any factors with eigenvalues lower than 
ones that were randomly generated (dashed line) should be rejected (Hayton et al., 2004), again 
supporting the single-factor solution. 
  
 
  
B2: Factor analysis and internal consistency of the TOD questionnaire. The first factor explained 43% of the variance at baseline, and 
46% at follow-up. 
 
Item 
Initial Clinical Evaluation End of Active Treatment 
Factor 
Loading Communality 
Item 
Alpha 
Factor 
Loading Communality 
Item 
Alpha 
1. Increase emotional support .35 .50 .91 .50 .38 .92 
2. Challenge depressing thoughts and images .65 .61 .90 .65 .50 .92 
3. Challenge depressing beliefs and attitudes .68 .64 .90 .76 .66 .91 
4. Challenge negative ideas about self .70 .66 .90 .74 .59 .91 
5. Identify counterproductive coping strategies .59 .35 .91 .66 .45 .92 
6. Cope with hard realities of life .71 .51 .90 .72 .52 .91 
7. Review priorities, values, or goals .69 .48 .90 .67 .50 .92 
8. Cope with everyday hassles and problems .73 .53 .90 .71 .54 .92 
9. Improve social life .64 .47 .90 .64 .66 .92 
10. Increase pleasant activities .66 .45 .90 .70 .68 .91 
11. Increase productive activities .71 .53 .90 .67 .57 .92 
12. Active problem-solving .74 .56 .90 .76 .61 .91 
13. Overcome adversity .67 .51 .90 .74 .59 .91 
14. Relaxation and stress management .62 .40 .90 .69 .49 .92 
15. Improve skills for difficult social situations .74 .55 .90 .67 .46 .92 
16. Manage health problems or health care .54 .29 .91 .58 .36 .92 
B3: Inter-item correlations 
 
Baseline correlation matrix 
             Item 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
1 1.00 
               2 .16 1.00 
              3 .14 .60 1.00 
             4 .13 .54 .58 1.00 
            5 .28 .41 .33 .43 1.00 
           6 .24 .44 .39 .51 .43 1.00 
          7 .23 .35 .36 .46 .43 .54 1.00 
         8 .22 .41 .44 .51 .41 .61 .55 1.00 
        9 .25 .36 .29 .38 .40 .38 .42 .41 1.00 
       10 .26 .45 .43 .36 .33 .39 .34 .39 .53 1.00 
      11 .25 .41 .46 .41 .32 .39 .45 .47 .48 .63 1.00 
     12 .30 .42 .48 .44 .34 .54 .50 .50 .44 .41 .55 1.00 
    13 .31 .36 .40 .37 .31 .41 .46 .46 .37 .42 .46 .52 1.00 
   14 .20 .32 .43 .38 .30 .35 .42 .39 .34 .38 .46 .48 .45 1.00 
  15 .27 .42 .45 .42 .43 .48 .48 .51 .48 .41 .52 .53 .50 .50 1.00 
 16 .12 .26 .38 .25 .26 .37 .33 .41 .31 .33 .31 .39 .40 .29 .38 1.00 
 
All correlations are significant at p<.05 
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Follow-up 
correlation 
matrix 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
1 1.00 
               2 .30 1.00 
              3 .29 .67 1.00 
             4 .30 .55 .60 1.00 
            5 .36 .35 .42 .53 1.00 
           6 .31 .42 .56 .45 .44 1.00 
          7 .27 .35 .48 .44 .43 .49 1.00 
         8 .19 .40 .53 .52 .41 .44 .53 1.00 
        9 .48 .26 .35 .44 .32 .43 .32 .40 1.00 
       10 .34 .39 .50 .41 .35 .48 .36 .40 .58 1.00 
      11 .30 .40 .40 .43 .34 .44 .35 .38 .46 .68 1.00 
     12 .35 .48 .61 .53 .49 .55 .51 .49 .44 .42 .41 1.00 
    13 .27 .42 .51 .52 .51 .51 .54 .53 .37 .41 .45 .59 1.00 
   14 .26 .39 .45 .43 .46 .43 .36 .44 .39 .52 .47 .47 .41 1.00 
  15 .25 .28 .42 .40 .40 .40 .39 .46 .44 .44 .40 .46 .52 .52 1.00 
 16 .32 .32 .34 .35 .30 .37 .38 .47 .37 .38 .32 .37 .32 .40 .45 1.00 
 
All correlations are significant at p<.01 
